Health risk assessment of environmental selenium: Emerging evidence and challenges (Review)

Molecular Medicine Reports

Volumn 15, Issue 5, 2017, Pages 3323-3335

  Vinceti, Marco ^a   Filippini, Tommaso ^a   Cilloni, Silvia ^a   Bargellini, Annalisa ^a   Vergoni, Anna Valeria ^a   Tsatsakis, Aristides ^b   Ferrante, Margherita ^c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF CRETE   (Greece)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Biochemistry; Environment; Epidemiology; Risk assessment; Selenium

Indexed keywords

SELENIUM; ORGANOSELENIUM DERIVATIVE;

ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGY; HEALTH HAZARD; HUMAN; REVIEW; RISK ASSESSMENT; STANDARD; CARDIOMYOPATHY; CLINICAL TRIAL (TOPIC); DIETARY SUPPLEMENT; ENTEROVIRUS INFECTION; NEOPLASM; POLLUTANT;

CARDIOMYOPATHIES; CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; ENTEROVIRUS INFECTIONS; ENVIRONMENTAL POLLUTANTS; HUMANS; NEOPLASMS; ORGANOSELENIUM COMPOUNDS; RISK ASSESSMENT; SELENIUM;

EID: 85018690271     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2017.6377     Document Type: Review

References (121)

1. Vinceti M, Dennert G, Crespi CM, Zwahlen M, Brinkman M, Zeegers MP, Horneber M, D'Amico R and Del Giovane C: Selenium for preventing cancer. Cochrane Database Syst Rev 3: CD005195, 2014.
2. Lance P, Alberts DS, Thompson PA, Fales L, Wang F, San Jose J, Jacobs ET, Goodman PJ, Darke AK, Yee M, et al: Colorectal adenomas in participants of the SELECT randomized trial of selenium and vitamin E for prostate cancer prevention. Cancer Prev Res (Phila) 10: 45-54, 2017.
3. Thompson PA, Ashbeck EL, Roe DJ, Fales L, Buckmeier J, Wang F, Bhattacharyya A, Hsu CH, Chow HH, Ahnen DJ, et al: Selenium supplementation for prevention of colorectal adenomas and risk of associated type 2 diabetes. J Natl Cancer Inst 108: pii: djw152, 2016.
4. Institute of Medicine Food and Nutrition Board: Dietary references intakes for vitamin C, vitamin E, selenium, and carotenoids. National Academy Press, Washington, DC, 2000.
5. Vinceti M, Crespi CM, Bonvicini F, Malagoli C, Ferrante M, Marmiroli S and Stranges S: The need for a reassessment of the safe upper limit of selenium in drinking water. Sci Total Environ 443: 633-642, 2013.
6. Rothman KJ, Greenland S and Lash TL: Modern Epidemiology. Lippincott Williams & Wilkins, Philadelphia, 2012.
7. Michalke B, Halbach S and Nischwitz V: JEM spotlight: Metal speciation related to neurotoxicity in humans. J Environ Monit 11: 939-954, 2009.
8. Gammelgaard B, Jackson MI and Gabel-Jensen C: Surveying selenium speciation from soil to cell-forms and transformations. Anal Bioanal Chem 399: 1743-1763, 2011.
9. Weekley CM and Harris HH: Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease. Chem Soc Rev 42: 8870-8894, 2013.
10. Vinceti M, Solovyev N, Mandrioli J, Crespi CM, Bonvicini F, Arcolin E, Georgoulopoulou E and Michalke B: Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite. Neurotoxicology 38: 25-32, 2013.
11. Vinceti M, Grill P, Malagoli C, Filippini T, Storani S, Malavolti M and Michalke B: Selenium speciation in human serum and its implications for epidemiologic research: A cross-sectional study. J Trace Elem Med Biol 31: 1-10, 2015.
12. Vinceti M, Wei ET, Malagoli C, Bergomi M and Vivoli G: Adverse health effects of selenium in humans. Rev Environ Health 16: 233-251, 2001.
13. Vinceti M, Mandrioli J, Borella P, Michalke B, Tsatsakis A and Finkelstein Y: Selenium neurotoxicity in humans: Bridging laboratory and epidemiologic studies. Toxicol Lett 230: 295-303, 2014.
14. Vinceti M, Crespi CM, Malagoli C, Del Giovane C and Krogh V: Friend or foe? The current epidemiologic evidence on selenium and human cancer risk. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 31: 305-341, 2013.
15. Vinceti M, Burlingame B, Fillippini T, Naska A, Bargellini A and Borella P: The epidemiology of selenium and human health. In: Selenium: Its Molecular Biology and Role in Human Health. Hatfeld D, Schweizer U and Gladyshev VN (eds). 4th edition. Springer Science Business Media, New York, pp365-376, 2016.
16. Joint FAO/WHO Expert Consultation on Human Vitamin and Mineral Requirements: Vitamin and mineral requirements in human nutrition. 2nd edition. World Health Organization and Food and Agriculture Organization of the United Nations, Geneva, 2004.
17. Keshan Disease Research Group of the Chinese Academy of Medical Sciences: Epidemiologic studies on the etiologic relationship of selenium and Keshan disease. Chin Med J (Engl) 92: 477-482, 1979.
18. Keshan Disease Research Group of the Chinese Academy of Medical Sciences: Observations on effect of sodium selenite in prevention of Keshan disease. Chin Med J (Engl) 92: 471-476, 1979.
19. Wang T and Li Q: Interpretation of selenium deficiency and Keshan disease with causal inference of modern epidemiology. In: The 5th International Selenium Seminar. Organizing Committee of the International Selenium Seminar, Moscow, pp34-35, 2015.
20. Lei C, Niu X, Ma X and Wei J: Is selenium defciency really the cause of Keshan disease? Environ Geochem Health 33: 183-188, 2011.
21. Winther KH, Bonnema SJ, Cold F, Debrabant B, Nybo M, Cold S and Hegedüs L: Does selenium supplementation affect thyroid function? Results from a randomized, controlled, double-blinded trial in a Danish population. Eur J Endocrinol 172: 657-667, 2015.
22. Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Combs GF, Cappuccio FP, Ceriello A and Reid ME: Effects of long-term selenium supplementation on the incidence of type 2 diabetes: A randomized trial. Ann Intern Med 147: 217-223, 2007.
23. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, et al: Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301: 39-51, 2009.
24. Vinceti M, Rovesti S, Gabrielli C, Marchesi C, Bergomi M, Martini M and Vivoli G: Cancer mortality in a residential cohort exposed to environmental selenium through drinking water. J Clin Epidemiol 48: 1091-1097, 1995.
25. Vinceti M, Rothman KJ, Bergomi M, Borciani N, Serra L and Vivoli G: Excess melanoma incidence in a cohort exposed to high levels of environmental selenium. Cancer Epidemiol Biomarkers Prev 7: 853-856, 1998.
26. Vinceti M, Ballotari P, Steinmaus C, Malagoli C, Luberto F, Malavolti M and Giorgi Rossi P: Long-term mortality patterns in a residential cohort exposed to inorganic selenium in drinking water. Environ Res 150: 348-356, 2016.
27. Saint-Amour D, Roy MS, Bastien C, Ayotte P, Dewailly E, Després C, Gingras S and Muckle G: Alterations of visual evoked potentials in preschool Inuit children exposed to methylmercury and polychlorinated biphenyls from a marine diet. Neurotoxicology 27: 567-578, 2006.
28. Vinceti M, Bonvicini F, Rothman KJ, Vescovi L and Wang F: The relation between amyotrophic lateral sclerosis and inorganic selenium in drinking water: A population-based case-control study. Environ Health 9: 77, 2010.
29. Vinceti M and Rothman KJ: More results but no clear conclusion on selenium and cancer. Am J Clin Nutr 104: 245-246, 2016.
30. Hughes DJ, Duarte-Salles T, Hybsier S, Trichopoulou A, Stepien M, Aleksandrova K, Overvad K, Tjønneland A, Olsen A, Affret A, et al: Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort. Am J Clin Nutr 104: 406-414, 2016.
31. Ma X, Yang Y, Li HL, Zheng W, Gao J, Zhang W, Yang G, Shu XO and Xiang YB: Dietary trace element intake and liver cancer risk: Results from two population-based cohorts in China. Int J Cancer 140: 1050-1059, 2017.
32. Knekt P, Marniemi J, Teppo L, Heliövaara M and Aromaa A: Is low selenium status a risk factor for lung cancer? Am J Epidemiol 148: 975-982, 1998.
33. van den Brandt PA, Goldbohm RA, van 't Veer P, Bode P, Dorant E, Hermus RJ and Sturmans F: A prospective cohort study on selenium status and the risk of lung cancer. Cancer Res 53: 4860-4865, 1993.
34. Suadicani P, Hein HO and Gyntelberg F: Serum selenium level and risk of lung cancer mortality: A 16-year follow-up of the Copenhagen Male Study. Eur Respir J 39: 1443-1448, 2012.
35. Menkes MS, Comstock GW, Vuilleumier JP, Helsing KJ, Rider AA and Brookmeyer R: Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. N Engl J Med 315: 1250-1254, 1986.
36. van Noord PA, Maas MJ, van der Tweel I and Collette C: Selenium and the risk of postmenopausal breast cancer in the DOM cohort. Breast Cancer Res Treat 25: 11-19, 1993.
37. van den Brandt PA, Goldbohm RA, van't Veer P, Bode P, Dorant E, Hermus RJ and Sturmans F: Toenail selenium levels and the risk of breast cancer. Am J Epidemiol 140: 20-26, 1994.
38. Garland M, Morris JS, Stampfer MJ, Colditz GA, Spate VL, Baskett CK, Rosner B, Speizer FE, Willett WC and Hunter DJ: Prospective study of toenail selenium levels and cancer among women. J Natl Cancer Inst 87: 497-505, 1995.
39. Clark LC, Combs GFJ Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, et al; Nutritional Prevention of Cancer Study Group: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. JAMA 276: 1957-1963, 1996.
40. Jablonska E and Vinceti M: Selenium and Human Health: Witnessing a Copernican Revolution? J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 33: 328-368, 2015.
41. Higgins JP: A revised tool to assess risk of bias in randomized trials (RoB 2.0). 2016.
42. Rees K, Hartley L, Day C, Flowers N, Clarke A and Stranges S: Selenium supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 1: CD009671, 2013.
43. Stratton MS, Reid ME, Schwartzberg G, Minter FE, Monroe BK, Alberts DS, Marshall JR and Ahmann FR: Selenium and prevention of prostate cancer in high-risk men: The Negative Biopsy Study. Anticancer Drugs 14: 589-594, 2003.
44. Algotar AM, Stratton MS, Ahmann FR, Ranger-Moore J, Nagle RB, Thompson PA, Slate E, Hsu CH, Dalkin BL, Sindhwani P, et al: Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer. Prostate 73: 328-335, 2013.
45. Karp DD, Lee SJ, Keller SM, Wright GS, Aisner S, Belinsky SA, Johnson DH, Johnston MR, Goodman G, Clamon G, et al: Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597. J Clin Oncol 31: 4179-4187, 2013.
46. Kristal AR, Darke AK, Morris JS, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL Jr, Goodman GE, Minasian LM, Parnes HL, et al: Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk. J Natl Cancer Inst 106: djt456, 2014.
47. Albanes D, Till C, Klein EA, Goodman PJ, Mondul AM, Weinstein SJ, Taylor PR, Parnes HL, Gaziano JM, Song X, et al: Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Prev Res (Phila) 7: 886-895, 2014.
48. Martinez EE, Darke AK, Tangen CM, Goodman PJ, Fowke JH, Klein EA and Abdulkadir SA: A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Prev Res (Phila) 7: 950-957, 2014.
49. Duffield-Lillico AJ, Slate EH, Reid ME, Turnbull BW, Wilkins PA, Combs GF Jr, Park HK, Gross EG, Graham GF, Stratton MS, et al; Nutritional Prevention of Cancer Study Group: Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J Natl Cancer Inst 95: 1477-1481, 2003.
50. Dréno B, Euvrard S, Frances C, Moyse D and Nandeuil A: Effect of selenium intake on the prevention of cutaneous epithelial lesions in organ transplant recipients. Eur J Dermatol 17: 140-145, 2007.
51. Lubinski J, Jaworska K, Durda K, Jakubowska A, Huzarski T, Byrski T, Stawicka M, Gronwald J, Górski B, Wasowicz W, et al: Selenium and the risk of cancer in BRCA1 carriers. Hered Cancer Clin Pract 9 (Suppl 2): A5, 2011.
52. Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GFJ Jr, Slate EH, Fischbach LA, Marshall JR and Clark LC: Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: A summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 11: 630-639, 2002.
53. Duffield-Lillico AJ, Dalkin BL, Reid ME, Turnbull BW, Slate EH, Jacobs ET, Marshall JR and Clark LC; Nutritional Prevention of Cancer Study Group: Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: An analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int 91: 608-612, 2003.
54. Vinceti M, Maraldi T, Bergomi M and Malagoli C: Risk of chronic low-dose selenium overexposure in humans: Insights from epidemiology and biochemistry. Rev Environ Health 24: 231-248, 2009.
55. Yang GQ, Wang SZ, Zhou RH and Sun SZ: Endemic selenium intoxication of humans in China. Am J Clin Nutr 37: 872-881, 1983.
56. Barron E, Migeot V, Rabouan S, Potin-Gautier M, Séby F, Hartemann P, Lévi Y and Legube B: The case for re-evaluating the upper limit value for selenium in drinking water in Europe. J Water Health 7: 630-641, 2009.
57. Frisbie SH, Mitchell EJ and Sarkar B: Urgent need to reevaluate the latest World Health Organization guidelines for toxic inorganic substances in drinking water. Environ Health 14: 63, 2015.
58. Scientific Committee on Food: Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of Selenium. European Commission, Brussels, 2000. https://ec. europa.eu/food/sites/food/fles/safety/docs/sci-com-scf-out80g-en.pdf.
59. Tsubota-Utsugi M, Imai E, Nakade M, Tsuboyama-Kasaoka N, Morita A and Tokudome S: Dietary Reference Intakes for Japanese -2010. The summary report from the Scientific Committee of 'Dietary Reference intakes for Japanese'. National Institute of Health and Nutrition, Japan, 2012.
60. Nordic Nutrition Recommendations 2012. 5th edition. Nordic Council of Ministers, Copenhagen, 2014. doi: org/10.6027/Nord2014-002.
61. Società Italiana di Nutrizione Umana: LARN -Livelli di assunzione di riferimento di nutrienti e energia per la popolazione italiana -IV revisione. SICS, Milan, 2014 (In Italian).
62. Marschall TA, Bornhorst J, Kuehnelt D and SchwerdtleT: Differing cytotoxicity and bioavailability of selenite, methylselenocysteine, selenomethionine, selenosugar 1 and trimethylselenonium ion and their underlying metabolic transformations in human cells. Mol Nutr Food Res 60: 2622-2632, 2016.
63. Lazard M, Dauplais M, Blanquet S and Plateau P: Transsulfuration pathway seleno-amino acids are mediators of selenomethionine toxicity in Saccharomyces cerevisiae. J Biol Chem 290: 10741-10750, 2015.
64. Raine JC, Lallemand L, Pettem CM and Janz DM: Effects of chronic dietary selenomethionine exposure on the visual system of adult and F1 generation zebrafsh (Danio rerio). Bull Environ Contam Toxicol 97: 331-336, 2016.
65. Dolgova NV, Hackett MJ, MacDonald TC, Nehzati S, James AK, Krone PH, George GN and Pickering IJ: Distribution of selenium in zebrafish larvae after exposure to organic and inorganic selenium forms. Metallomics 8: 305-312, 2016.
66. Göen T, Schaller B, Jäger T, Bräu-Dümler Ch, Schaller KH and Drexler H: Biological monitoring of exposure and effects in workers employed in a selenium-processing plant. Int Arch Occup Environ Health 88: 623-630, 2015.
67. Jäger T, Drexler H and Göen T: Human metabolism and renal excretion of selenium compounds after oral ingestion of sodium selenate dependent on trimethylselenium ion (TMSe) status. Arch Toxicol 90: 149-158, 2016.
68. Ito K, Mathes R, Ross Z, Nádas A, Thurston G and Matte T: Fine particulate matter constituents associated with cardiovascular hospitalizations and mortality in New York City. Environ Health Perspect 119: 467-473, 2011.
69. Heck JE, Park AS, Qiu J, Cockburn M and Ritz B: Risk of leukemia in relation to exposure to ambient air toxics in pregnancy and early childhood. Int J Hyg Environ Health 217: 662-668, 2014.
70. Burk RF Jr: Selenium deficiency in search of a disease. Hepatology 8: 421-423, 1988.
71. Yu FF, Liu H and Guo X: Integrative multivariate logistic regression analysis of risk factors for Kashin-Beck disease. Biol Trace Elem Res 174: 274-279, 2016.
72. Yu FF, Zhang YX, Zhang LH, Li WR, Guo X and Lammi MJ: Identifed molecular mechanism of interaction between environmental risk factors and differential expression genes in cartilage of Kashin-Beck disease. Medicine (Baltimore) 95: e5669, 2016.
73. Beck MA, Levander OA and Handy J: Selenium defciency and viral infection. J Nutr 133 (Suppl 1): 1463S-1467S, 2003.
74. Sheridan PA, Zhong N, Carlson BA, Perella CM, Hatfeld DL and Beck MA: Decreased selenoprotein expression alters the immune response during influenza virus infection in mice. J Nutr 137: 1466-1471, 2007.
75. Gu BQ: Pathology of Keshan disease. A comprehensive review. Chin Med J (Engl) 96: 251-261, 1983.
76. Levander OA and Beck MA: Interacting nutritional and infectious etiologies of Keshan disease. Insights from coxsackie virus B-induced myocarditis in mice defcient in selenium or vitamin E. Biol Trace Elem Res 56: 5-21, 1997.
77. Xu GL, Wang SC, Gu BQ, Yang YX, Song HB, Xue WL, Liang WS and Zhang PY: Further investigation on the role of selenium defciency in the aetiology and pathogenesis of Keshan disease. Biomed Environ Sci 10: 316-326, 1997.
78. Chen J: An original discovery: Selenium defciency and Keshan disease (an endemic heart disease). Asia Pac J Clin Nutr 21: 320-326, 2012.
79. Guanqing H: On the etiology of Keshan disease: Two hypotheses. Chin Med J (Engl) 92: 416-422, 1979.
80. Cermelli C, Vinceti M, Scaltriti E, Bazzani E, Beretti F, Vivoli G and Portolani M: Selenite inhibition of Coxsackie virus B5 replication: Implications on the etiology of Keshan disease. J Trace Elem Med Biol 16: 41-46, 2002.
81. Schoenmakers E, Agostini M, Mitchell C, Schoenmakers N, Papp L, Rajanayagam O, Padidela R, Ceron-Gutierrez L, Doffnger R, Prevosto C, et al: Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein defciency disorder in humans. J Clin Invest 120: 4220-4235, 2010.
82. Scoto M, Cirak S, Mein R, Feng L, Manzur AY, Robb S, Childs AM, Quinlivan RM, Roper H, Jones DH, et al: SEPN1-related myopathies: Clinical course in a large cohort of patients. Neurology 76: 2073-2078, 2011.
83. Ardissone A, Bragato C, Blasevich F, Maccagnano E, Salerno F, Gandioli C, Morandi L, Mora M and Moroni I: SEPN1-related myopathy in three patients: Novel mutations and diagnostic clues. Eur J Pediatr 175: 1113-1118, 2016.
84. Schomburg L, Dumitrescu AM, Liao XH, Bin-Abbas B, Hoeflich J, Köhrle J and Refetoff S: Selenium supplementation fails to correct the selenoprotein synthesis defect in subjects with SBP2 gene mutations. Thyroid 19: 277-281, 2009.
85. EFSA NDA Panel: Scientifc opinion on dietary reference values for selenium. EFSA J 12: 3846, 2014.
86. Ge KY, Wang SQ, Bai J, Xue AN, Deng XJ, Su CQ and Wu SQ: The protective effect of selenium against viral myocarditis in mice. In: Selenium in biology and medicine. Part B. Combs GF, Spallholz JE, Levander OA and Oldfeld JE (eds). Avi Book, Van Nostrand Reinhold Co., New York, pp761-768, 1987.
87. Spallholz JE: Free radical generation by selenium compounds and their prooxidant toxicity. Biomed Environ Sci 10: 260-270, 1997.
88. Stewart MS, Spallholz JE, Neldner KH and Pence BC: Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic Biol Med 26: 42-48, 1999.
89. Letavayová L, Vlasáková D, Spallholz JE, Brozmanová J and Chovanec M: Toxicity and mutagenicity of selenium compounds in Saccharomyces cerevisiae. Mutat Res 638: 1-10, 2008.
90. Misra S, Boylan M, Selvam A, Spallholz JE and Björnstedt M: Redox-active selenium compounds -from toxicity and cell death to cancer treatment. Nutrients 7: 3536-3556, 2015.
91. Lee KH and Jeong D: Bimodal actions of selenium essential for antioxidant and toxic pro-oxidant activities: The selenium paradox (Review). Mol Med Rep 5: 299-304, 2012.
92. Brozmanová J, Mániková D, Vlčková V and Chovanec M: Selenium: A double-edged sword for defense and offence in cancer. Arch Toxicol 84: 919-938, 2010.
93. Schiar VP, Dos Santos DB, Paixão MW, Nogueira CW, Rocha JB and Zeni G: Human erythrocyte hemolysis induced by selenium and tellurium compounds increased by GSH or glucose: A possible involvement of reactive oxygen species. Chem Biol Interact 177: 28-33, 2009.
94. Guo CH, Hsia S, Hsiung DY and Chen PC: Supplementation with selenium yeast on the prooxidant-antioxidant activities and anti-tumor effects in breast tumor xenograft-bearing mice. J Nutr Biochem 26: 1568-1579, 2015.
95. Hafeman DG, Sunde RA and Hoekstra WG: Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J Nutr 104: 580-587, 1974.
96. Oh SH, Sunde RA, Pope AL and Hoekstra WG: Glutathione peroxidase response to selenium intake in lambs fed a Torula yeast-based, artifcial milk. J Anim Sci 42: 977-983, 1976.
97. Kramer GF and Ames BN: Mechanisms of mutagenicity and toxicity of sodium selenite (Na2SeO3) in Salmonella typhimurium. Mutat Res 201: 169-180, 1988.
98. Macallan DC and Sedgwick P: Selenium supplementation and selenoenzyme activity. Clin Sci (Lond) 99: 579-581, 2000.
99. Tsongas TA and Ferguson SW: Selenium concentrations in human urine and drinking water. In: Proceedings of 'Trace Elements in Man and Animal-3'. Kirchgessner N (ed). Institute for Nursing Physiology Technical University Munchen, Freising, pp320-321, 1978.
100. Tsongas TA and Ferguson SW: Human health effects of selenium in a rural Colorado drinking water supply. In: Proceedings of 'Trace substances in environmental health-XI. A symposium'. Hemphill DD (ed). University of Missouri, Columbia, pp30-35, 1977.
101. Valentine JL: Environmental occurrence of selenium in waters and related health signifcance. Biomed Environ Sci 10: 292-299, 1997.
102. Valentine JL, Kang HK, Dang PM and Schluchter M: Selenium concentrations and glutathione peroxidase activities in a population exposed to selenium via drinking water. J Toxicol Environ Health 6: 731-736, 1980.
103. Valentine JL, Faraji B and Kang HK: Human glutathione peroxidase activity in cases of high selenium exposures. Environ Res 45: 16-27, 1988.
104. Valentine JL, Reisbord LS, Kang HK and Schluchter M: Effects on human health of exposure to selenium in drinking water. In: Proceedings of 'Selenium in Biology and Medicine -Part B'. Combs GF, Levander OA, Spallholz JE and Oldfeld JE (eds). Van Nostrand Reihold Co., New York, pp675-687, 1987.
105. Longnecker MP, Taylor PR, Levander OA, Howe M, Veillon C, McAdam PA, Patterson KY, Holden JM, Stampfer MJ, Morris JS, et al: Selenium in diet, blood, and toenails in relation to human health in a seleniferous area. Am J Clin Nutr 53: 1288-1294, 1991.
106. Brätter P and Negretti de Brätter VE: Influence of high dietary selenium intake on the thyroid hormone level in human serum. J Trace Elem Med Biol 10: 163-166, 1996.
107. Fordyce FM, Zhan G, Green K and Liu X: Soil, grain and water chemistry in relation to human selenium-responsive diseases in Enshi District, China. Applied Geochemistry 15: 117-132, 2000. doi: 10.1016/S0883-2927(99)00035-9.
108. Zhu J, Wang N, Li S, Li L, Su H and Liu C: Distribution and transport of selenium in Yutangba, China: Impact of human activities. Sci Total Environ 392: 252-261, 2008.
109. Hira CK, Partal K and Dhillon KS: Dietary selenium intake by men and women in high and low selenium areas of Punjab. Public Health Nutr 7: 39-43, 2004.
110. Lemire M, Fillion M, Frenette B, Passos CJ, Guimarães JR, Barbosa F Jr and Mergler D: Selenium from dietary sources and motor functions in the Brazilian Amazon. Neurotoxicology 32: 944-953, 2011.
111. Lemire M, Philibert A, Fillion M, Passos CJ, Guimarães JR, Barbosa F Jr and Mergler D: No evidence of selenosis from a selenium-rich diet in the Brazilian Amazon. Environ Int 40: 128-136, 2012.
112. Qin HB, Zhu JM, Liang L, Wang MS and Su H: The bioavailability of selenium and risk assessment for human selenium poisoning in high-Se areas, China. Environ Int 52: 66-74, 2013.
113. Martens IB, Cardoso BR, Hare DJ, Niedzwiecki MM, Lajolo FM, Martens A and Cozzolino SM: Selenium status in preschool children receiving a Brazil nut-enriched diet. Nutrition 31: 1339-1343, 2015.
114. Chawla R, Loomba R, Chaudhary RJ, Singh S and Dhillon KS: Impact of high selenium exposure on organ function and biochemical profle of the rural population living in seleniferous soils in Punjab, India. In: Global advance in selenium research from theory to application. CRC Press, Sao Paulo, pp93-94, 2015.
115. Yu SY, Zhu YJ and Li WG: Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol Trace Elem Res 56: 117-124, 1997.
116. Yu SY, Zhu YJ, Li WG, Huang QS, Huang CZ, Zhang QN and Hou C: A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biol Trace Elem Res 29: 289-294, 1991.
117. Li WG: Preliminary observations on effect of selenium yeast on high risk populations with primary liver cancer. Zhonghua Yu Fang Yi Xue Za Zhi 26: 268-271, 1992 (In Chinese).
118. Li W, Zhu Y, Yan X, Zhang Q, Li X, Ni Z, Shen Z, Yao H and Zhu J: The prevention of primary liver cancer by selenium in high risk populations. Zhonghua Yu Fang Yi Xue Za Zhi 34: 336-338, 2000 (In Chinese).
119. Lotan Y, Goodman PJ, Youssef RF, Svatek RS, Shariat SF, Tangen CM, Thompson IM Jr and Klein EA: Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECT. J Urol 187: 2005-2010, 2012.
120. Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, et al: Vitamin E and the risk of prostate cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 306: 1549-1556, 2011.
121. Marshall JR, Tangen CM, Sakr WA, Wood DP Jr, Berry DL, Klein EA, Lippman SM, Parnes HL, Alberts DS, Jarrard DF, et al: Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res (Phila) 4: 1761-1769, 2011.